PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE

Autor: Francisco José Jiménez Nájar, Belén Olivares Pérez, Alicia Aguirre Lora, Noelia Romero Mata, Estefanía García Torres, Carmen Martín Calvo

Publikováno v: HemaSphere, Vol 7, p e80344a9 (2023)

Externí odkaz: https://doaj.org/article/813164a2f14e4f9896053b597fc6e7f0

Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?

Autor: Clara Aparicio-Pérez, Esther Prados de la Torre, Joaquin Sanchez-Garcia, Carmen Martín-Calvo, Carmen Martínez-Losada, Javier Casaño-Sanchez, Juana Serrano-López, Josefina Serrano

Publikováno v: Cancers
Volume 15
Issue 5
Pages: 1425

Acute myeloid leukemia (AML) is a heterogeneous disease classified into three risk categories (favorable, intermediate and adverse) with significant differences in outcomes. Definitions of risk categories evolve overtime, incorporating advances in mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c10538398509bb7eb9da5cc760eefd7d
https://doi.org/10.3390/cancers15051425

Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group

Autor: Ana Julia Gonzalez-Huerta, Guiomar Bautista, Anabella Chinea, José Luis Piñana, Santiago Leguey Jiménez, Carlos Vallejo, Estela Giménez, Tamara Torrado, Albert Esquirol, Ildefonso Espigado, Javier López-Jiménez, Raquel Saldaña, María Ángeles Cuesta, Lourdes Vázquez, Rafael de la Cámara, María Suárez-Lledó, Carlos Solano, Montserrat Rovira, Montserrat Batlle, Aránzazu Bermúdez, Carmen Martín Calvo, Inmaculada Heras, Eliseo Albert, Ariadna Pérez, Pere Barba, David Fraile Navarro

Publikováno v: American Journal of Transplantation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
AMERICAN JOURNAL OF TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Fundacion Sancho el Sabio Fundazioa (FSS)
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

The net impact of cytomegalovirus (CMV) DNAemia on overall mortality (OM) and nonrelapse mortality (NRM) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains a matter of debate. This was a retrospective, multicenter, nonin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eabeb80037fa175684b5c31c8119baa4
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4342

Post-Transplant Cyclophosphamide after HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of Geth-TC

Autor: Mercedes Colorado, Oriana López-Godino, Rebeca Bailén, Arancha Bermúdez, Beatriz Herruzo, Maria Jesus Pascual-Cascon, Mi Kwon, Jose J. Rifon Roca, Melissa Torres, Carmen Martín Calvo, Marta Fonseca, Jaime Sanz, Lucía López Corral, Inmaculada Heras, Antonia Sampol, Anabelle Chinea, José Luis Díez-Martín, Manuel Guerreiro, Leyre Bento, Gillen Oarbeascoa, Estefania García-Torres, Pilar Herrera

Publikováno v: Blood. 138:3913-3913

Introduction: High-dose post transplant cyclophosphamide (PTCY) effectively prevents graft-versus-host disease (GVHD) after unmanipulated HLA-haploidentical hematopoietic stem cell transplant (HSCT) and offer low rates of GVHD in the setting of HLA i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b1fe7015eba64346a1bb83820dba5336
https://doi.org/10.1182/blood-2021-150835